Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
|ClinicalTrials.gov Identifier: NCT00817752|
Recruitment Status : Completed
First Posted : January 6, 2009
Last Update Posted : March 18, 2010
|Condition or disease||Intervention/treatment||Phase|
|Inflammation Cancer Autoimmune Diseases||Dietary Supplement: Ashwagandha||Phase 1|
Due to the increased use of alternative medicine, supplements and herbs are consumed more frequently in the treatment of common ailments. This pilot study investigates the immune, anti-inflammatory and anti-stress effects of Ashwagandha in human subjects.
Liquid extract of the herb will be taken followed by milk; this mode of administration will be used as it approximates the traditional administration as well as making self administration easier for participants. Extract will be taken in 3 milliliter quantities 2 times per day, (morning and evening), for five days. Total dosage of 6 milliliters will approximate the higher end of the traditional daily dosage of 6 grams daily of powdered root.
Flow of visit:
25 participants will arrive at the research lab and after being consented, filling out health histories and two stress questionnaires, (POMS and STAI Self-Evaluation), average milk intake questionnaire. The 25 participants will receive blood draws. They will then be administered the herb extract, milk and instructions for taking them.
Subjects will return to the research institute after 24 hours for a second blood draw and then after 5 days for a final blood draw and two more stress questionnaires, (POMS and STAI Self-Evaluation).
Once the blood samples are drawn, they will be refrigerated and processed within 24 hours at the NCNM laboratory. Initially they will be centrifuged to separate the white from the red blood cells using Ficoll separating tubes. Then the white blood cells will be stained using CD69 marker (Cytokine Detection type 69) which assesses cell-surface phenotypic markers in combination with intracellular cytokines, measuring response to activation. It is especially effective for rare-event, antigen-specific events, such as the administration of a specific immune-stimulating herbal tincture. We will also stain with other similar florescent CD markers specific for CD4 T-cells, CD8 T-cells, B-cells, NK cells, and macrophages. These markers will be analyzed using a FACScan flow cytometer, which will count the number of cells that have been activated in each subtype of the immune cell and overall action. Blood will also be analyzed for cortisol levels and inflammatory cytokines, (IL-1, IL-6 and TNF-alpha) using the ELISA assay procedure.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation|
|Study Start Date :||May 2007|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||February 2008|
Receives Ashwagandha herb.
Dietary Supplement: Ashwagandha
Participants consume 3mL of Ashwagandha for 5 days. Blood work/immune cells (CD4 T-cells, CD8 T-cells, B-cells, NK cells, macrophages, IL-1, IL-6 and TNF-alpha) and psychological assessments (POMS and STAI Self-Evaluation) given at specified time intervals.
- The primary endpoint of this study will be to measure immune cell activation, inflammatory cytokines and cortisol levels after administration of the herb. [ Time Frame: 24 hours and again at 5 days ]
- The secondary endpoint of this study will be to measure and correlate stress levels to the use of the herb. [ Time Frame: 24 hours and again at 5 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00817752
|United States, Oregon|
|Helfgott Research Institute|
|Portland, Oregon, United States, 97201|
|Principal Investigator:||Heather Zwickey, PhD||Helfgott Research Institute at NCNM|